Teva/Barr Get The Green Light To Continue Marketing Generic Allegra
This article was originally published in The Pink Sheet Daily
Executive Summary
A New Jersey federal judge denied Sanofi-Aventis' request for a preliminary injunction to stop Teva/Barr from marketing generic Allegra.
You may also be interested in...
Allegra Authorized Generic Scripts Could Reach 40% By Year-End, Sanofi Says
Teva describes the launch of its generic fexofenadine as one of the firm’s “most successful.”
Teva Launches Generic Allegra “At Risk” Under Barr’s Exclusivity
Barr could take a one-time charge this quarter for estimated liability related to Teva's "at risk" launch of generic Allegra under Barr's exclusivity
NEJM, JAMA Editorials Give Opposing Opinions Of Mandatory HPV Vaccination
Two of the leading medical journals are offering opposing viewpoints on mandatory human papilloma virus vaccination, with experts contributing perspective pieces that directly reflect the larger political and social division over the issue